342 related articles for article (PubMed ID: 10705306)
1. Aerosolized interferon-alpha treatment in patients with multi-drug-resistant pulmonary tuberculosis.
Giosuè S; Casarini M; Ameglio F; Zangrilli P; Palla M; Altieri AM; Bisetti A
Eur Cytokine Netw; 2000 Mar; 11(1):99-104. PubMed ID: 10705306
[TBL] [Abstract][Full Text] [Related]
2. Effects of aerosolized interferon-alpha in patients with pulmonary tuberculosis.
Giosué S; Casarini M; Alemanno L; Galluccio G; Mattia P; Pedicelli G; Rebek L; Bisetti A; Ameglio F
Am J Respir Crit Care Med; 1998 Oct; 158(4):1156-62. PubMed ID: 9769275
[TBL] [Abstract][Full Text] [Related]
3. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
Saito W; Nagayama N; Miyamoto M; Hara H; Suzuki J; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H
Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568
[TBL] [Abstract][Full Text] [Related]
4. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
5. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.
Park SK; Kim JH; Kang H; Cho JS; Smego RA
Int J Infect Dis; 2009 Mar; 13(2):170-5. PubMed ID: 18768342
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic accuracy of cytokine levels (TNF-alpha, IL-2 and IFN-gamma) in bronchoalveolar lavage fluid of smear-negative pulmonary tuberculosis patients.
Küpeli E; Karnak D; Beder S; Kayacan O; Tutkak H
Respiration; 2008; 75(1):73-8. PubMed ID: 17975298
[TBL] [Abstract][Full Text] [Related]
7. [Tuberculosis in compromised hosts].
Kekkaku; 2003 Nov; 78(11):717-22. PubMed ID: 14672050
[TBL] [Abstract][Full Text] [Related]
8. Treatment of 171 patients with pulmonary tuberculosis resistant to isoniazid and rifampin.
Goble M; Iseman MD; Madsen LA; Waite D; Ackerson L; Horsburgh CR
N Engl J Med; 1993 Feb; 328(8):527-32. PubMed ID: 8426619
[TBL] [Abstract][Full Text] [Related]
9. Tuberculosis chemotherapy and sputum conversion among HIV-seropositive and HIV-seronegative patients in south-eastern Uganda.
Bwire R; Borgdorff MW; Sticht-Groh V; Rieder HL; Kawuma HJ; Bretzel G; Rüsch-Gerdes S
East Afr Med J; 1999 Jun; 76(6):307-13. PubMed ID: 10750516
[TBL] [Abstract][Full Text] [Related]
10. [Study on the efficacy and safety of short-term treatment including fluoroquinolones anti-tuberculosis drugs for rifampicin resistant pulmonary tuberculosis].
Kang WL; Xie YG; Tan WG; Chu NH; Li L; You YH; Yang YZ; Wang XM; Yan XL; Miao ZP; Duanmu HJ
Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Feb; 30(2):179-83. PubMed ID: 19565883
[TBL] [Abstract][Full Text] [Related]
11. Subcutaneously administered interferon-gamma for the treatment of multidrug-resistant pulmonary tuberculosis.
Park SK; Cho S; Lee IH; Jeon DS; Hong SH; Smego RA; Cho SN
Int J Infect Dis; 2007 Sep; 11(5):434-40. PubMed ID: 17321178
[TBL] [Abstract][Full Text] [Related]
12. Tuberculosis recurrence and mortality after successful treatment: impact of drug resistance.
Cox H; Kebede Y; Allamuratova S; Ismailov G; Davletmuratova Z; Byrnes G; Stone C; Niemann S; Rüsch-Gerdes S; Blok L; Doshetov D
PLoS Med; 2006 Oct; 3(10):e384. PubMed ID: 17020405
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and tolerability of daily-half dose linezolid in patients with intractable multidrug-resistant tuberculosis.
Park IN; Hong SB; Oh YM; Kim MN; Lim CM; Lee SD; Koh Y; Kim WS; Kim DS; Kim WD; Shim TS
J Antimicrob Chemother; 2006 Sep; 58(3):701-4. PubMed ID: 16857689
[TBL] [Abstract][Full Text] [Related]
14. [Multi-drug resistant lung tuberculosis due to double infection of MDR strain].
Ito K; Takahashi M; Yoshiyama T; Wada M; Ogata H
Kekkaku; 2004 Jun; 79(6):387-90. PubMed ID: 15293752
[TBL] [Abstract][Full Text] [Related]
15. Treatment outcome of relapse and defaulter pulmonary tuberculosis patients.
Sevim T; Ataç G; Güngör G; Törün I; Aksoy E; Gemci ; Tahaoglu K
Int J Tuberc Lung Dis; 2002 Apr; 6(4):320-5. PubMed ID: 11936741
[TBL] [Abstract][Full Text] [Related]
16. Risk of acquired drug resistance during short-course directly observed treatment of tuberculosis in an area with high levels of drug resistance.
Cox HS; Niemann S; Ismailov G; Doshetov D; Orozco JD; Blok L; Rüsch-Gerdes S; Kebede Y
Clin Infect Dis; 2007 Jun; 44(11):1421-7. PubMed ID: 17479936
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of kanamycin, ethionamide, PAS and cycloserine in multidrug-resistant pulmonary tuberculosis patients.
Prasad R; Verma SK; Sahai S; Kumar S; Jain A
Indian J Chest Dis Allied Sci; 2006; 48(3):183-6. PubMed ID: 18610675
[TBL] [Abstract][Full Text] [Related]
18. Changes in the levels of interferon-gamma and transforming growth factor-beta influence bronchial stenosis during the treatment of endobronchial tuberculosis.
Kim Y; Kim K; Joe J; Park H; Lee M; Kim Y; Choi Y; Park S
Respiration; 2007; 74(2):202-7. PubMed ID: 17124378
[TBL] [Abstract][Full Text] [Related]
19. [A case of multi-drug resistant pulmonary tuberculosis after administration of standard anti-tuberculosis treatment for two times].
Wakabayashi K; Yano S; Kobayashi K; Tokuda Y; Ikeda T; Ishikawa S; Takeyama H
Kekkaku; 2008 Jul; 83(7):513-7. PubMed ID: 18709969
[TBL] [Abstract][Full Text] [Related]
20. Adjunctive salvage therapy with inhaled aminoglycosides for patients with persistent smear-positive pulmonary tuberculosis.
Sacks LV; Pendle S; Orlovic D; Andre M; Popara M; Moore G; Thonell L; Hurwitz S
Clin Infect Dis; 2001 Jan; 32(1):44-9. PubMed ID: 11118385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
